Polycystic ovarian syndrome-current pharmacotherapy and clinical implicationsRumaisa Rashid, Ghulam Nabi Bader, Rifat Ara et al.|Taiwanese Journal of Obstetrics and Gynecology|2022Cited by 142
Evaluation of the Safety and Efficacy of Ormeloxifene, a Selective Estrogen Receptor Modulator and Medroxyprogesterone Acetate in Women with Non-Structural Abnormal Uterine Bleeding: A Randomized Clinical TrialSuhail Ahmad Mir, Faiyaz Shakeel, Rifat Ara et al.|Medicina|2022Cited by 5